The mechanism of action of partial splenic artery embolization in treatment of liver cirrhosis and hypersplenism
10.3969/j.issn.1001-5256.2023.07.029
- VernacularTitle:部分脾动脉栓塞治疗肝硬化脾功能亢进的作用机制
- Author:
Zongwei LI
1
;
Yaqin WANG
2
;
Yuewei ZHANG
2
Author Information
1. Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qinghai University, Xining 810001, China
2. Department of Hepatobiliary Intervention, Beijing Tsinghua Changgung Hospital, Beijing 102218, China
- Publication Type:Review
- Keywords:
Liver Cirrhosis;
Hypertension, Portal;
Hypersplenism
- From:
Journal of Clinical Hepatology
2023;39(7):1714-1720
- CountryChina
- Language:Chinese
-
Abstract:
Hypersplenism is a common complication caused by liver cirrhosis and portal hypertension, and at present, splenectomy and partial splenic artery embolization (PSE) are the main methods for the treatment of hypersplenism. Splenectomy has a marked effect in the treatment of hypersplenism and can significantly improve the clinical symptoms of patients with hypersplenism. Compared with splenectomy, PSE causes partial splenic parenchymal infarction and thus achieve similar clinical efficacy as partial splenectomy while preserving the spleen and its function. Although PSE is an effective method for the treatment of hypersplenism, there are few reports on the effect of PSE on liver fibrosis, immunity, and liver regeneration in China and globally. This article summarizes the common causes of hypersplenism, the mechanism of PSE in the treatment of hypersplenism, the therapeutic effect of different embolization methods and materials, and the effect of PSE on liver fibrosis, immunity, and liver regeneration, so as to provide a theoretical basis and new ideas for the clinical treatment of hypersplenism.
